The Global Herpes Zoster Treatment Market is expected to witness a CAGR of 4% during the forecast period. Shingles (herpes zoster) is a viral infection that causes an outbreak of a painful rash or blisters on the skin. It's caused by the varicella-zoster virus, which is the same virus that causes chickenpox. It is a common disease in immunocompromised individuals and in the old-aged population. In this disease, the chickenpox virus becomes dormant and re-activates when immunity compromises. The rising geriatric population is one of the important factors that is responsible for the increasing cases of shingles. For instance, as per the WHO, Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. Therefore, increasing demand for effective treatment is expected to drive the global herpes zoster treatment market at a significant growth rate during the forecast period.
Unlock The Table of Content, And Request a Sample Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=28000
According to UnivDatos Market Insights (UMI)’ research report “Global Herpes Zoster Treatment Market”, the market is expected to witness robust growth during the forecast period (2022-2028). This is mainly due to the growing number of cases of shingles.
Based on treatment type, the market has been categorized into antiviral medications, anti-inflammatory medications, and others. Among them, the antiviral category is expected to witness lucrative growth during the forecast period. Active participation of the government in the vaccination programs and the rising demand for antiviral drugs attributed to the growth of the segment in the herpes zoster treatment market. For instance, In 2013, the Shingles National Immunization Programme was introduced by the U.K. Department of Health. In September 2020, all eligible 70 to 79-year-olds were included in the program.
Unlock The Table of Content, And Request a Sample Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=28000
Based on the route of administration, the market has been categorized into oral, topical, and others. Among them, the oral segment is expected to have significant growth in the market. The rising demand for an effective and easier route of administration is catalyzing the market growth of oral drugs. Furthermore, increasing the adoption of antiviral drugs is also an important factor that affects the market for oral drugs.
Based on the distribution channel, the market is segmented into retail pharmacies, online pharmacies, hospital pharmacies, and others. Hospital pharmacies are expected to witness lucrative growth during the forecast period. This is mainly due to the rising number of hospitalization cases and the increasing number of old-aged patients affected by the disease. For instance, the Canadian Institute of Health Information, the hospitalization rate was 6,687 per 100,000 in 2020–2021.
North America to witness extensive growth
For a better understanding of the market adoption of the herpes zoster treatment industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America constitutes a significant herpes zoster treatment market due to the increasing RD activities for developing a better and rising geriatric population in the region. Furthermore, the rise the public awareness about the severity of the disease is also responsible for the market growth of the treatment in the region. Additionally, the presence of developed nations such as the U.S in the region and their higher healthcare expenditure and better infrastructure is also responsible for the lucrative market share of the region in the shingles treatment market. For instance, U.S. health care spending grew 9.7 percent in 2020, reaching $4.1 trillion or $12,530 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 19.7 percent.
For More Informative Information, Please Visit Us – https://univdatos.com/report/herpes-zoster-treatment-market/
According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Herpes Zoster Treatment market are Abbott Laboratory, Bausch Health, Cipla Inc., Camber Pharmaceuticals., GlaxoSmithKline plc, Merck, Novartis AG, Pfizer Inc., Eli Lilly and Co., and Teva Pharmaceutical Industries Ltd.
“Global Herpes Zoster Treatment Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on different parameters. This will help companies in the formulation of go-to-market strategies and identifying the blue ocean for its offerings.
Market Segmentation:
- By Treatment Type (Antiviral Medications, Anti-Inflammatory Medications, and Others)
- By Route of Administration (Oral, Topical, and Others)
- By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies, and Others)
- By Region (North America, Europe, Asia-Pacific, Rest of the World)
- By Company (Abbott Laboratory, Bausch Health, Cipla Inc., Camber Pharmaceuticals., GlaxoSmithKline plc, Merck, Novartis AG, Pfizer Inc., Eli Lilly and Co., and Teva Pharmaceutical Industries Ltd.)
Key questions answered in the study:
- What are the current and future trends of the global herpes zoster treatment industry?
- How the industry has been evolving in terms of treatment type, route of administration, and distribution channel?
- How the competition has been shaping across the countries followed by their comparative factorial indexing?
- What are the key growth drivers and challenges for the global herpes zoster treatment industry?
- What is the customer orientation, purchase behavior, and expectations from the global s suppliers across various region and countries?
